Government regulators must steward drug transparency.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25100518.
- Also identified by DOI 10.1038/nm0814-806.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The pharmaceutical industry has recently taken steps to make clinical trial data more accessible. But for there to be meaningful transparency, governments—not drug companies—should set the terms of disclosure.
Medical subject headings
- Clinical Trials as Topic
- Disclosure
- Drug Industry